Personalized Medicine – Webinars and Online Events

Driving biomarker discovery is key as proteomics emerges as the next frontier in precision medicine.
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.

We are thrilled to present an exclusive AMA featuring the distinguished Professor Mark Lawler, PhD, FRCPath.

This exclusive on-demand AMA event grants you unprecedented access to the pioneering expert Prof. Donald Ingber, delving deep into the captivating realm of body-on-a-chip technology– completely free of charge.

This online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organs-on-chips and key modeling strategies, as well as how research advances are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.

Returning for its third year, this online symposium will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. From uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

Accessed via mobile, tablet or PC, this free-to-attend inaugural online symposium will provide cancer researchers with a unique opportunity to hear about the advances taking place within omics research, immunology, drug discovery and other notable topics.

Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least two distinct types of cytokine signatures induced by SARS-CoV-2 infection.

This online symposium will highlight the latest advances in proteomics and metabolomics research and their applications in modern medicine.

During this webinar, we will discuss our hiPSC-derived cortical and sensory neurons, co-culture and their electrophysiological characterization using microelectrode arrays (MEA). The focus is on the development of disease models, co-culture, pharmacology and neurotoxicity screening.

During this webinar, we will discuss our hiPSC-derived cardiomyocytes and a custom service we provide for their electrophysiological characterization using microelectrode arrays (MEA). The focus is on the development of disease models and cardiotoxicity screening.